Company Filing History:
Years Active: 2015-2016
Title: Syuzanna Harutyunyan: Innovator in Pharmaceutical Chemistry
Introduction
Syuzanna Harutyunyan is a prominent inventor based in Groningen, Netherlands. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit viral replication.
Latest Patents
Harutyunyan holds two patents, both related to the macrocyclic protease inhibitor TMC 435. Her latest patents describe an improved process for preparing a specific intermediate compound essential for the synthesis of TMC 435. This compound plays a crucial role in inhibiting the NS3/4A protease, which is vital for the replication of the hepatitis C virus.
Career Highlights
Syuzanna is currently employed at Janssen Pharmaceuticals, Inc., where she continues her research and development efforts. Her work focuses on innovative solutions to combat viral infections, showcasing her dedication to improving public health.
Collaborations
Throughout her career, Harutyunyan has collaborated with notable colleagues, including Andras Horvath and Stijn Wuyts. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion
Syuzanna Harutyunyan is a key figure in the pharmaceutical industry, with her inventions paving the way for new treatments against hepatitis C. Her work exemplifies the impact of innovation in healthcare.